Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02696226 · ClinicalTrials.gov registry record · NA
Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02696226 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 3 participants.
The verdict
NCT02696226, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This is a prospective, randomized pilot study in patients undergoing Sugical Aortic Valve Replacement (SAVR) and Transcatheter Aortic Valve Replacement (TAVR) to estimate the incidence of reduced leaflet motion and assess the impact of perioperative anticoagulation on the incidence of reduced leaflet motion.
Interventions
- DRUG SAVR Warfarin
- DRUG SAVR Aspirin
- DRUG TAVR Warfarin and clopidogrel
- DRUG TAVR Aspirin and clopidogrel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-07-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02696226
The ClinicalTrials.gov registry entry for NCT02696226 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which SAVR Warfarin is the first listed.
NCT02696226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02696226 about?
NCT02696226 is a clinical study titled "Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.". This is a prospective, randomized pilot study in patients undergoing Sugical Aortic Valve Replacement (SAVR) and Transcatheter Aortic Valve Replacement (TAVR) to estimate the incidence of reduced leaflet motion and assess the impact of perioperative anticoagulation on the incidence of reduced leafle...
What is the current status of trial NCT02696226?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2016-02. Estimated completion is 2017-07-28.
What interventions are being tested in trial NCT02696226?
The interventions under investigation include: SAVR Warfarin (DRUG), SAVR Aspirin (DRUG), TAVR Warfarin and clopidogrel (DRUG), TAVR Aspirin and clopidogrel (DRUG).
Who is sponsoring clinical trial NCT02696226?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.